It's surprising how much pharmaceutical research to date has been more art than science. Computing power is still a long way off predicting the properties of proteins and cells from their DNA, so until then the more research that can be accelerated by automation (e.g. lab robots, lab-on-chip) the better.
And this is being driven by the big pharma companies who can't afford the failure rate at late stage drug development, or worse after release which can result in multi-billion law suits. I attended an excellenty talk by the chief scientific office for GE Healthcare recently and they are mass producing stem cell lines, and the machinery to test them, so that drugs can be tested for cardio-toxicity much earlier on in the development process.
Japanese multinational pharmaceutical and biopharmaceutical company.
Pharmaceutical company focused on the development of novel drugs for the treatment of diabetes.
Biopharmaceutical company focused on the discovery and commercialization of novel therapies..
Fast generation of functional therapeutic antibodies.
Pharmaceutical company that develops a novel class of medicines by targeting damaged cells.
Company focused on development of novel and proprietary technologies for pharmaceuticals and diagnostics.
Company discovering, developing and delivering innovative medicines to patients with serious diseases.
Drug discovery and development company.
Pharmaceutical company that develops drugs for neurodegenerative diseases.
Biomedical company researching the biology of aging and developing drugs for age related diseases.
Laboratory Automation Blog Posts
Scientists manufactures artificial organoids using automation
Lab Manager - 11-Nov-2020
Semi-automating tissue differentiation makes artificial tissues at a faster rateRead more...
IBM develops an online chemistry lab 'RoboRXN'
MIT Technology Review - 28-Aug-2020
Will lower the cost & speed up the process of developing drugsRead more...
Robotic scientists can do lab work faster
BBC - 06-Jul-2020
Does not mean that machines will be able to replace human scientistsRead more...